Total Payments
$8,276
2023 Payments
$794.12
Companies
33
Transactions
492
Medicare Patients
4,144
Medicare Billing
$803,204
Payment Breakdown by Category
Food & Beverage$8,080 (97.6%)
Education$195.36 (2.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,080 | 488 | 97.6% |
| Education | $195.36 | 4 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,560 | 144 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,699 | 128 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,475 | 76 | $0 (2023) |
| PFIZER INC. | $371.22 | 26 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $300.61 | 14 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $259.82 | 10 | $0 (2023) |
| GENZYME CORPORATION | $218.66 | 12 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $152.21 | 4 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $124.96 | 8 | $0 (2019) |
| Genentech USA, Inc. | $111.45 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $794.12 | 39 | AstraZeneca Pharmaceuticals LP ($195.24) |
| 2022 | $1,424 | 68 | AstraZeneca Pharmaceuticals LP ($515.19) |
| 2021 | $1,364 | 80 | AstraZeneca Pharmaceuticals LP ($467.48) |
| 2020 | $1,059 | 63 | AstraZeneca Pharmaceuticals LP ($379.79) |
| 2019 | $1,092 | 75 | AstraZeneca Pharmaceuticals LP ($375.58) |
| 2018 | $1,104 | 73 | GlaxoSmithKline, LLC. ($268.01) |
| 2017 | $1,439 | 94 | AstraZeneca Pharmaceuticals LP ($362.94) |
All Payment Transactions
492 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/10/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Education | In-kind items and services | $89.99 | General |
| Category: Cardiology | ||||||
| 07/27/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Respiratory | ||||||
| 07/26/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: IMMUNOLOGY | ||||||
| 07/21/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Respiratory | ||||||
| 07/19/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Immunology | ||||||
| 07/18/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: RESPIRATORY | ||||||
| 07/12/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: RESPIRATORY | ||||||
| 07/05/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/16/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Respiratory | ||||||
| 06/14/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Immunology | ||||||
| 06/09/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.61 | General |
| 05/31/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: RESPIRATORY | ||||||
| 05/27/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Oncology | ||||||
| 05/24/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Respiratory | ||||||
| 05/19/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: RESPIRATORY | ||||||
| 05/17/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Immunology | ||||||
| 05/13/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: IMMUNOLOGY | ||||||
| 05/05/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.79 | General |
| 05/04/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/27/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: RESPIRATORY | ||||||
| 04/27/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Respiratory | ||||||
| 04/21/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ARALAST (Biological) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: IMMUNOLOGY | ||||||
| 04/12/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/06/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/29/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,215 | 2,613 | $868,968 | $235,603 |
| 2022 | 10 | 994 | 2,240 | $552,441 | $192,859 |
| 2021 | 9 | 922 | 2,210 | $501,921 | $209,020 |
| 2020 | 9 | 1,013 | 2,241 | $478,304 | $165,722 |
Total Patients
4,144
Total Services
9,304
Medicare Billing
$803,204
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 604 | 1,286 | $423,510 | $120,852 | 28.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 236 | 809 | $178,680 | $54,205 | 30.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 142 | 159 | $100,137 | $23,618 | 23.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 82 | 82 | $49,969 | $13,058 | 26.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 15 | 70 | $68,742 | $12,961 | 18.9% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 12 | 56 | $24,693 | $5,215 | 21.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 28 | $6,200 | $1,634 | 26.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 28 | 28 | $5,488 | $1,417 | 25.8% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 28 | 28 | $5,320 | $1,357 | 25.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 14 | 14 | $2,468 | $480.62 | 19.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 39 | $2,221 | $469.51 | 21.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 14 | 14 | $1,540 | $334.74 | 21.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 473 | 1,150 | $278,463 | $96,990 | 34.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 203 | 697 | $104,456 | $42,318 | 40.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 118 | 131 | $54,772 | $21,378 | 39.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 80 | 80 | $39,703 | $13,486 | 34.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 23 | 61 | $49,127 | $11,224 | 22.8% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 13 | 33 | $11,913 | $3,147 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 33 | 34 | $5,900 | $1,985 | 33.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 18 | 19 | $3,173 | $1,007 | 31.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 18 | 19 | $3,173 | $937.07 | 29.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 15 | 16 | $1,760 | $387.23 | 22.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 459 | 1,161 | $277,024 | $106,434 | 38.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 196 | 629 | $91,704 | $38,468 | 41.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 33 | 176 | $54,808 | $33,529 | 61.2% |
About Dr. Robert Johnson, MD
Dr. Robert Johnson, MD is a Pulmonary Disease healthcare provider based in Goshen, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205858024.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Johnson, MD has received a total of $8,276 in payments from pharmaceutical and medical device companies, with $794.12 received in 2023. These payments were reported across 492 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($8,080).
As a Medicare-enrolled provider, Johnson has provided services to 4,144 Medicare beneficiaries, totaling 9,304 services with total Medicare billing of $803,204. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Internal Medicine, Pulmonary Disease
- Location Goshen, NY
- Active Since 07/24/2006
- Last Updated 10/04/2024
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1205858024
Products in Payments
- BREZTRI (Drug) $1,078
- TRELEGY ELLIPTA (Drug) $1,068
- SYMBICORT (Drug) $605.54
- STIOLTO RESPIMAT (Drug) $550.75
- OFEV (Drug) $489.91
- BEVESPI AEROSPHERE (Drug) $467.18
- DUPIXENT (Biological) $462.82
- ELIQUIS (Drug) $282.59
- ACTHAR (Biological) $280.01
- BREO (Drug) $177.56
- BREZTRI AEROSPHERE (Drug) $169.28
- ANORO (Drug) $145.73
- ANORO ELLIPTA (Drug) $138.81
- OPSUMIT (Drug) $126.50
- NUCALA (Biological) $125.43
- CHANTIX (Drug) $88.63
- FASENRA (Drug) $88.21
- GLASSIA (Biological) $80.00
- STIOLTO (Drug) $71.59
- Xolair (Biological) $70.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.